Thalassemia Minor and Major: Current Management

Area of Science:

• Genetics
• Hematology
• Pediatrics

Background:

• Thalassemia is a prevalent genetic disorder with a significant carrier rate in India.
• Asymptomatic carriers require monitoring for iron deficiency anemia.
• Thalassemia major necessitates early diagnosis and intensive management from infancy.

Purpose of the Study:

• To summarize the current understanding and management of thalassemia in India.
• To highlight the importance of early diagnosis and treatment for thalassemia major.
• To discuss curative options like bone marrow transplantation.

Main Methods:

• Review of existing literature and clinical guidelines for thalassemia management.
• Analysis of epidemiological data regarding thalassemia carriers and major cases in India.
• Discussion of therapeutic strategies including blood transfusions, chelation therapy, and bone marrow transplantation.

Main Results:

• India has a high prevalence of thalassemia carriers, estimated at 5 crore people.
• Approximately 12,000 children are born annually with thalassemia major.
• Effective management, including maintaining serum ferritin around 1000 ng/ml, allows near-normal life for affected children.
• Bone marrow transplantation offers a cure, with best outcomes in children under 7 years of age.

Conclusions:

• Comprehensive management protocols have greatly improved outcomes for children with thalassemia.
• Bone marrow transplantation is a potentially curative option for thalassemia major.
• Continued research and public health initiatives are crucial for thalassemia control and care.